SCHEMBL2197161

SCHEMBL2197161

O=COC1(OCc2ccccc2)CC(=O)NC1=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 2/20 0.42
CRBN Q96SW2 2/20 0.42
MAOA P21397 4/20 0.35
MAOB P27338 4/20 0.35
POLB P06746 2/20 0.35
HPGD P15428 1/20 0.35
PTPN1 P18031 1/20 0.35
HTT P42858 2/20 0.35
ALDH1A1 P00352 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MMP2 P08253 1/20 0.34
MMP13 P45452 1/20 0.34
KDM4E B2RXH2 1/20 0.34
TTR P02766 1/20 0.34
BLM P54132 1/20 0.34
PLA2G1B P04054 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4942764 0.75 DDB1 (0.43) DDB1CRBNMAOAMAOBHTT
SCHEMBL10352633 0.74 DDB1 (0.40) DDB1CRBNMAOAMAOBPOLB
SCHEMBL19028118 0.67 ALDH1A1 (0.39) MAOBHTTALDH1A1MEN1KMT2A
SCHEMBL10611547 0.67 DDB1 (0.62) DDB1CRBNALDH1A1KMT2AMMP2
SCHEMBL12424729 0.66 DDB1 (0.47) DDB1CRBNPOLBHTTALDH1A1
SCHEMBL2361135 0.66 DDB1 (0.77) DDB1CRBNALDH1A1KMT2AMMP2
SCHEMBL5552459 0.65 DDB1 (0.59) DDB1CRBNALDH1A1KMT2AMMP2
SCHEMBL4528306 0.64 DDB1 (0.51) DDB1CRBNALDH1A1MEN1KMT2A
SCHEMBL23705024 0.64 ALDH1A1 (0.46) MAOBALDH1A1MEN1KMT2AMMP2
SCHEMBL11281090 0.64 DDB1 (0.36) DDB1CRBNMAOAMAOBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350118-B1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2016-03-30 EP disclosed
US-9173951-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2015-11-03 US disclosed
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2015-02-19 US disclosed
US-8680263-B2 Carbohydrate-based drug delivery polymers and conjugates thereof NEKTAR THERAPEUTICS (US) 2014-03-25 US disclosed
EP-2350118-A2 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF Nektar Therapeutics (US) 2011-08-03 EP disclosed
US-20110171716-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2011-07-14 US disclosed
WO-2010033240-A2 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF NEKTAR THERAPEUTICS (US) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171716-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST DDB1 1372/4885CRBN 964/4885MAOA 3698/4885
US-20150051371-A1 CARBOHYDRATE-BASED DRUG DELIVERY POLYMERS AND CONJUGATES THEREOF STT3B, STT3A, DDOST DDB1 1372/4885CRBN 964/4885MAOA 3698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.